RSV Therapeutics LLC
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Efficacy and Safety of XC221 in Patients With Mild COVID-19 (NCT04940182) | RSV Therapeutics LLC | 2021-06-26 |
| A Study to Assess the Efficacy and Safety of XC221 in Patients With COVID-19 (NCT04487574) | RSV Therapeutics LLC | 2020-07-25 |
Track RSV Therapeutics LLC automatically
Every clearance here is in the API, with alerts when new ones post.